Development/validation of a molecular and clinical evidence-based algorithm for selecting optimal precision therapeutic strategy for cancer patients-continuous studyCANCER RESEARCHIF16.62024-03-220PRE
Differential gut microbiome alpha diversity in endometrial and ovarian carcinoma patientsCANCER RESEARCHIF16.62024-03-220PRE
Mutational signatures and their associations with social determinants of healthCANCER RESEARCHIF16.62024-03-220PRE
Development/validation of a molecular and clinical evidence-based algorithm for selecting optimal precision therapeutic strategy for cancer patientsCANCER RESEARCHIF16.62023-04-040PRE
Case report-16 year life history and genomic evolution of an ER+HER2-breast cancerCANCER RESEARCHIF16.62020-02-150PRE
Clinical benefit of molecularly-guided treatment strategies on progression free survival in patients with advanced gastrointestinal malignanciesCANCER RESEARCHIF16.62019-07-010PRE
Tolerability and outcomes of trametinib and everolimus combinations in advanced solid tumorsCANCER RESEARCHIF16.62018-07-010PRE
Assessment of the efficacy and safety of checkpoint inhibitors in the treatment of solid-tumor malignancies in a community cancer hospitalCANCER RESEARCHIF16.62018-07-010PRE